Cathie Wood’s ARK ETF has published their daily trades for Friday, March 7th, 2025, showcasing a series of strategic buy and sell actions across various sectors. In the latest trading session, ARK’s most significant transaction involved the sale of 332,402 shares of UiPath Inc (NYSE:PATH), amounting to a total dollar value of $3,905,723. The sale was distributed among three ARK funds, with ARKK, ARKQ, and ARKW parting with 237,840, 11,003, and 83,559 shares, respectively.
Another notable divestment was in Roku Inc (NASDAQ:ROKU), where ARK sold 28,229 shares across ARKK, ARKW, and ARKF ETFs for a combined value of $2,247,028. This continues a trend from the previous week, indicating a possible strategic shift away from the streaming device company.
On the purchasing side, ARK made a significant investment in Ibotta Inc (NASDAQ:IBTA), acquiring a total of 47,482 shares through ARKW and ARKF ETFs, with a total dollar value of $1,781,999. This follows a similar purchase the day before, suggesting ARK’s growing interest in the mobile technology company.
The investment firm also increased its position in Personalis Inc (NASDAQ:PSNL) by buying 73,781 shares for $311,355 through its ARKG ETF, adding to the previous day’s acquisition, which could signal a strong belief in the company’s long-term potential.
Further buys included 50,102 shares of Absci Corp (NASDAQ:ABSI) for $155,316 and 15,341 shares of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) for $95,727, both through the ARKG ETF. These transactions continue ARK’s pattern of investing in the health and biotech sectors.
Smaller scale transactions included the sale of 9,871 shares of Roblox Corp (NYSE:RBLX) across three ETFs for a total of $578,144, indicating a reduction in ARK’s exposure to the online gaming platform.
Investors and market watchers will likely analyze these trades to gain insights into ARK’s investment strategy and market outlook. The continued focus on health technology and a shift away from certain tech stocks could reflect ARK’s adaptation to changing market conditions or a reevaluation of company prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.